Key Takeaways
- • Saba Capital Management, the largest shareholder of Baillie Gifford US Growth Trust, has nominated three directors—Jason Chen, Thomas H. McGlade, and Sir James Waterlow—and is pushing for a 100% cash exit at or near net asset value for all shareholders.
- • The trust has significantly underperformed the S&P 500 over the past five years, lagging by 88.4% on a share-price basis and 79.1% on a net asset value basis, according to Saba's analysis.
- • Saba has achieved nine successful outcomes across its UK investment trust campaign over the past two years, including liquidity events and buybacks that the firm claims have generated substantial shareholder value.
- • The outcome of the upcoming AGM vote will determine whether Saba's nominees secure board seats and can advance the trust toward a full liquidity event.
Summary
The campaign centers on a core complaint: persistent underperformance coupled with a persistent discount to net asset value. Saba's analysis reveals that over the past five years, the trust has underperformed the S&P 500 by 88.4% on a share-price basis and 79.1% on an NAV basis, a gap the activist argues justifies radical action. This dual underperformance metric—comparing both share-price returns and NAV returns against the broader equity index—underscores the severity of the trust's structural challenges in Saba's view.
Saba's push at Baillie Gifford represents part of a broader activist strategy targeting UK investment trusts. The firm has reported nine successful outcomes from its campaign over the past two years, encompassing liquidity events and shareholder buybacks that it claims have created material value for investors. This track record provides the activist with credibility and a demonstrated framework for value creation, which it is now seeking to apply to Baillie Gifford.
The critical juncture arrives at the AGM vote. If Saba's nominees are elected to the board, they would have the authority and mandate to pursue a full liquidity event, potentially forcing a resolution to the underperformance and discount issues that have plagued the trust. The AGM outcome will determine whether Saba can translate its activist thesis into concrete action or whether the existing board maintains control of the trust's strategic direction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.